Longitudinal temperature measurement can determine humane endpoints in BALB/c mouse models of ESKAPEE infection

Longitudinal temperature measurement can determine humane endpoints in BALB/c mouse models of ESKAPEE infection

ABSTRACTAntimicrobial resistance (AMR) is a worldwide problem, which is driving more preclinical research to find new treatments and countermeasures for drug-resistant bacteria. However, translational models in the preclinical space have remained static for years. To improve animal use ethical consi...

Full description

Bibliographic Details
Main Authors:	Randal Scott Dudis, Ting Y. Wong, Mariel G. Escatte, Yonas A. Alamneh, Rania Abu-Taleb, Wanwen Su, Christine Czintos, Timothy A. Fitzgerald, Yoann Le Breton, Daniel V. Zurawski
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-12-01
Series:	Virulence
Subjects:	Temperature ESKAPEE murine pulmonary infection model BALB/c humane endpoints replacement, reduction, refinement (3Rs)
Online Access:	https://www.tandfonline.com/doi/10.1080/21505594.2023.2186331

Similar Items

Humane Endpoints in Swiss Webster Mice Infected with <i>Toxoplasma gondii</i> RH Strain
by: Igor Falco Arruda, et al.
Published: (2024-04-01)

Molecular characterization of multidrug-resistant ESKAPEE pathogens from clinical samples in Chonburi, Thailand (2017–2018)
by: Sirigade Ruekit, et al.
Published: (2022-08-01)

Evaluating the Role of Wastewaters as Reservoirs of Antibiotic-Resistant ESKAPEE Bacteria Using Phenotypic and Molecular Methods
by: Mustafa SS, et al.
Published: (2022-09-01)

The Resistome of ESKAPEE Pathogens in Untreated and Treated Wastewater: A Polish Case Study
by: Jakub Hubeny, et al.
Published: (2022-08-01)

Presence and Persistence of <i>ESKAPEE</i> Bacteria before and after Hospital Wastewater Treatment
by: Miguel Galarde-López, et al.
Published: (2024-06-01)

Potential involvement of beta-lactamase homologous proteins in resistance to beta-lactam antibiotics in gram-negative bacteria of the ESKAPEE group
by: Joyce de Souza, et al.
Published: (2024-05-01)

Engineered endolysin of Klebsiella pneumoniae phage is a potent and broad-spectrum bactericidal agent against “ESKAPEE” pathogens
by: Wei Chen, et al.
Published: (2024-05-01)

Concentration vs. Optical Density of ESKAPEE Bacteria: A Method to Determine the Optimum Measurement Wavelength
by: Bruno Wacogne, et al.
Published: (2024-12-01)

The effect of combinations of a glyphosate-based herbicide with various clinically used antibiotics on phenotypic traits of Gram-negative species from the ESKAPEE group
by: Hanane Zerrouki, et al.
Published: (2024-09-01)

Effectiveness of Efflux Pump Inhibitors as Biofilm Disruptors and Resistance Breakers in Gram-Negative (ESKAPEE) Bacteria
by: Akif Reza, et al.
Published: (2019-11-01)

Acinetobacter Baumannii – Virulence Factors and Epidemiology of Infections
by: Marszalik Anna, et al.
Published: (2021-12-01)

Endpoints: types, selection, interpretation of the results obtained on the example of cardiology studies
by: A. R. Navasardyan, et al.
Published: (2022-06-01)

ACINETOBACTER BAUMANNII – VIRULENCE FACTORS AND EPIDEMIOLOGY OF INFECTIONS
by: Anna Marszalik, et al.
Published: (2021-12-01)

Efficacy of PBTZ169 and pretomanid against Mycobacterium avium, Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum in BALB/c mice models
by: Luyao Zheng, et al.
Published: (2023-03-01)

Absorption/Attenuation Spectral Description of ESKAPEE Bacteria: Application to Seeder-Free Culture Monitoring, Mammalian T-Cell and Bacteria Mixture Analysis and Contamination Description
by: Bruno Wacogne, et al.
Published: (2023-04-01)

Study of methods for endpoint aware inspection in a next generation firewall
by: Jenny Heino, et al.
Published: (2022-09-01)

Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series
by: Michael S. Yule, et al.
Published: (2024-06-01)

Surrogate endpoints in trials: a call for better reporting
by: Oriana Ciani, et al.
Published: (2022-12-01)

First detection of dengue virus in the saliva of immunocompetent murine model
by: Arthur da Costa Rasinhas, et al.
Published: (2018-02-01)

When do we need clinical endpoint adjudication in clinical trials?
by: Claes Held
Published: (2019-01-01)

Inoculation of the <i>Leishmania infantum HSP70-II</i> Null Mutant Induces Long-Term Protection against <i>L. amazonensis</i> Infection in BALB/c Mice
by: Manuel Soto, et al.
Published: (2021-02-01)

Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series
by: James McDonald, et al.
Published: (2023-10-01)

Study on the Antibody Production Efficiency in Modified Big-BALB/c Mice
by: WANG Dan, et al.
Published: (2023-12-01)

The problems of Endpoint DLP systems
by: N. S. Morozova
Published: (2011-12-01)

Influence of three BALB/c substrain backgrounds on the skin tumor induction efficacy to DMBA and TPA cotreatment
by: Mi Ju Kang, et al.
Published: (2020-09-01)

Selection of Endpoints for Clinical Studies of Ophthalmic Drugs
by: M. O. Komarova
Published: (2021-10-01)

Short-term OS as a surrogate endpoint for 5-year OS in nasopharyngeal carcinoma in non-endemic area
by: Ying Guan, et al.
Published: (2024-07-01)

Evolution and optimization of clinical trial endpoints and design in pulmonary arterial hypertension
by: Marco Caccamo, et al.
Published: (2023-07-01)

Two Decades of Cardiovascular Trials With Primary Surrogate Endpoints: 1990–2011
by: Behnood Bikdeli, et al.
Published: (2017-03-01)

Guidewire Endpoint Detection Based on Pixel‐Adjacent Relation during Robot‐Assisted Intravascular Catheterization: In Vivo Mammalian Models
by: Wenjing Du, et al.
Published: (2024-04-01)

Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints series
by: Ola Magne Vagnildhaug, et al.
Published: (2024-04-01)

Inhibitory Effect of Mistletoe Ointment on DNCB-Induced Atopic Dermatitis in BALB/c Mice
by: Chang-Eui Hong, et al.
Published: (2023-12-01)

Immunomodulatory Effects of Tigecycline in Balb/C Mice
by: Elhayek Shada Y., et al.
Published: (2018-12-01)

Effects of Quinazolinones on the Development of BALB/c Mice
by: Maryam Shams Lahijani, et al.
Published: (2009-09-01)

Effects of date palm pollen on fertility and development of reproductive system in female Balb/C mice
by: Moshfegh Fazeleh, et al.
Published: (2016-01-01)

The health endpoint due to exposure organophosphorus toxicant
by: Yousef Nikmanesh, et al.
Published: (2024-01-01)

Correlation between clinical trial endpoints of marketed cancer drugs and reimbursement decisions in China
by: Kexin Ling, et al.
Published: (2022-11-01)

Interleukin-4 production in BALB/c mice immunized with Anisakis simplex
by: Perteguer María Jesús, et al.
Published: (2001-01-01)

A natural loss-of-function deletion of the cytohesin 1 (Cyth1) gene in BALB/cByJ mice does not impact cardiomyocyte polyploidy
by: Ruolan Song, et al.
Published: (2024-06-01)

Effects of Removing User-Land Hooks in Endpoint Protection During Attack Experiments
by: Trevor M. Lewis, et al.
Published: (2024-01-01)